F18.94
Inhalant use, unspecified with inhalant-induced mood disorder
Clinical Classification Guidelines
Inclusion Terms
- Inhalant induced depressive disorder
Medical Intelligence & Overview
Inhalant use involves inhaling chemical vapors to achieve a psychoactive effect. Some individuals who misuse inhalants develop mood disorders directly related to their inhalant use. Specifically, inhalant-induced mood disorder can include symptoms of depression and other emotional disturbances that occur during or after inhalant abuse. Recognizing and understanding these linked conditions are important steps in addressing inhalant misuse and its mental health consequences.
Causes & Symptoms
Clinical Causes: Repeated use of inhalants such as solvents, aerosols, gases, and adhesives Genetic predisposition towards substance use or mood disorders Psychological factors including stress, trauma, or underlying mental health issues Peer pressure or social environments that promote substance misuse Lack of awareness about the risks associated with inhalant use
Key Symptoms: Persistent feelings of sadness or depression Loss of interest in activities once enjoyed Mood swings or irritability Fatigue and decreased energy levels Difficulty concentrating Changes in sleep patterns, such as insomnia or hypersomnia Feelings of worthlessness or guilt In severe cases, thoughts of self-harm or suicide
Diagnostic & Treatment
Diagnosis Path: Diagnosing inhalant-induced mood disorder involves a thorough clinical assessment by healthcare professionals, including detailed patient history and physical examination. Doctors may conduct psychiatric evaluations to identify mood symptoms linked temporally to inhalant use. Laboratory tests or toxicology screens can confirm recent inhalant exposure. It’s important to differentiate between primary mood disorders and those induced by substance use, which can influence treatment strategies.
Treatment Protocols: Treatment approaches typically focus on addressing both the inhalant use and the associated mood disorder. These may include:
Clinical Advice & FAQs
Billing Guidance
Is F18.94 a billable ICD-10 code?
Yes, F18.94 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.94?
Clinical documentation must specify the nature of Inhalant use, unspecified with inhalant-induced mood disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference